Extracellular Vesicles in Corneal Fibrosis/Scarring.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
25 May 2022
Historique:
received: 25 04 2022
revised: 21 05 2022
accepted: 23 05 2022
entrez: 10 6 2022
pubmed: 11 6 2022
medline: 14 6 2022
Statut: epublish

Résumé

Communication between cells and the microenvironment is a complex, yet crucial, element in the development and progression of varied physiological and pathological processes. Accumulating evidence in different disease models highlights roles of extracellular vesicles (EVs), either in modulating cell signaling paracrine mechanism(s) or harnessing their therapeutic moiety. Of interest, the human cornea functions as a refractive and transparent barrier that protects the intraocular elements from the external environment. Corneal trauma at the ocular surface may lead to diminished corneal clarity and detrimental effects on visual acuity. The aberrant activation of corneal stromal cells, which leads to myofibroblast differentiation and a disorganized extracellular matrix is a central biological process that may result in corneal fibrosis/scarring. In recent years, understanding the pathological and therapeutic EV mechanism(s) of action in the context of corneal biology has been a topic of increasing interest. In this review, we describe the clinical relevance of corneal fibrosis/scarring and how corneal stromal cells contribute to wound repair and their generation of the stromal haze. Furthermore, we will delve into EV characterization, their subtypes, and the pathological and therapeutic roles they play in corneal scarring/fibrosis.

Identifiants

pubmed: 35682600
pii: ijms23115921
doi: 10.3390/ijms23115921
pmc: PMC9180085
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NEI NIH HHS
ID : P30 EY003790
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY005665
Pays : United States
Organisme : NEI NIH HHS
ID : EY005665
Pays : United States
Organisme : NEI NIH HHS
ID : EY03790
Pays : United States

Références

J Refract Surg. 2013 May;29(5):332-41
pubmed: 23659231
J Extracell Vesicles. 2013 Mar 19;2:
pubmed: 24009897
Acta Biomater. 2017 Aug;58:291-301
pubmed: 28559158
J Cell Mol Med. 2020 Oct;24(19):11254-11271
pubmed: 32845084
J Clin Invest. 2007 Mar;117(3):576-86
pubmed: 17332885
Chin Med J (Engl). 2018 Mar 20;131(6):704-712
pubmed: 29521294
Stem Cell Res Ther. 2020 Aug 12;11(1):350
pubmed: 32787917
Exp Eye Res. 2019 Apr;181:49-60
pubmed: 30660507
Clin Exp Optom. 2015 Mar;98(2):122-5
pubmed: 25308346
J Immunol. 2009 Aug 1;183(3):1884-91
pubmed: 19596992
Nat Cell Biol. 2010 Jan;12(1):19-30; sup pp 1-13
pubmed: 19966785
Circulation. 2021 Apr 6;143(14):1426-1449
pubmed: 33819075
Stem Cells Transl Med. 2019 Nov;8(11):1192-1201
pubmed: 31290598
Prog Retin Eye Res. 2004 Mar;23(2):195-228
pubmed: 15094131
Front Immunol. 2021 Apr 15;12:640595
pubmed: 33936055
Ophthalmology. 2015 Jun;122(6):1085-95
pubmed: 25795477
F1000 Biol Rep. 2011;3:15
pubmed: 21876726
J Extracell Vesicles. 2016 Sep 27;5:33109
pubmed: 27680302
J Cataract Refract Surg. 2005 Oct;31(10):2026-30
pubmed: 16338580
Cell Rep. 2019 Apr 16;27(3):940-954.e6
pubmed: 30956133
Acta Pharmacol Sin. 2018 Apr;39(4):501-513
pubmed: 29219950
Exp Eye Res. 2017 Aug;161:101-105
pubmed: 28506643
Stem Cells Transl Med. 2016 Oct;5(10):1425-1439
pubmed: 27388239
Cornea. 2005 Nov;24(8 Suppl):S2-S11
pubmed: 16227819
Saudi J Ophthalmol. 2014 Jul;28(3):168-72
pubmed: 25278792
J Funct Biomater. 2012 Sep 18;3(3):642-87
pubmed: 24955637
Fundam Clin Pharmacol. 2021 Feb;35(1):4-24
pubmed: 32298491
Stem Cells. 2016 Oct;34(10):2525-2535
pubmed: 27250866
Semin Cell Dev Biol. 2015 Apr;40:27-34
pubmed: 25662446
Exp Eye Res. 2003 Jan;76(1):71-87
pubmed: 12589777
Acta Pharmacol Sin. 2018 Apr;39(4):542-551
pubmed: 29417947
Sci Rep. 2018 Oct 11;8(1):15173
pubmed: 30310159
Exp Mol Med. 2020 Jun;52(6):887-895
pubmed: 32541816
Thorax. 2012 Jun;67(6):496-501
pubmed: 22106021
Stem Cell Res Ther. 2021 Mar 31;12(1):221
pubmed: 33789737
Biophys Rev. 2009 Jul;1(2):83-93
pubmed: 28509987
J Cell Sci. 1993 Oct;106 ( Pt 2):685-91
pubmed: 8282773
Front Cell Infect Microbiol. 2020 Dec 01;10:593170
pubmed: 33335862
Pediatr Nephrol. 2019 Jan;34(1):11-30
pubmed: 29181712
Curr Biol. 2009 Dec 1;19(22):1875-85
pubmed: 19896381
J Transl Med. 2015 Sep 19;13:308
pubmed: 26386558
J Lipid Res. 2018 Sep;59(9):1554-1560
pubmed: 29853529
Biochim Biophys Acta. 2009 Dec;1793(12):1901-16
pubmed: 19781582
Science. 2008 Feb 29;319(5867):1244-7
pubmed: 18309083
Anat Rec (Hoboken). 2020 Jun;303(6):1727-1734
pubmed: 31136100
Toxicol Pathol. 2007 Jun;35(4):495-516
pubmed: 17562483
J Med Chem. 2020 Oct 8;63(19):10533-10593
pubmed: 32482069
Blood Rev. 2007 May;21(3):157-71
pubmed: 17118501
Physiol Rev. 2016 Apr;96(2):605-45
pubmed: 26936867
Trends Immunol. 2018 Apr;39(4):288-301
pubmed: 29248310
Nucleic Acids Res. 2022 Jan 7;50(D1):D118-D128
pubmed: 34918744
Proteomics. 2009 Nov;9(21):4997-5000
pubmed: 19810033
Cell Death Discov. 2021 Nov 23;7(1):366
pubmed: 34815387
Pharmaceutics. 2021 Sep 23;13(10):
pubmed: 34683836
Cornea. 2015 Feb;34(2):117-59
pubmed: 25564336
Exp Cell Res. 2018 Sep 15;370(2):333-342
pubmed: 29964051
Invest Ophthalmol Vis Sci. 2019 Jan 2;60(1):294-303
pubmed: 30657854
Front Cell Dev Biol. 2021 Mar 16;9:647025
pubmed: 33796534
Nat Cell Biol. 2012 Jun 03;14(7):677-85
pubmed: 22660413
J Biol Chem. 1988 Dec 5;263(34):18205-12
pubmed: 2848029
Nat Med. 1998 May;4(5):594-600
pubmed: 9585234
Sci Rep. 2018 Aug 17;8(1):12377
pubmed: 30120298
J Cell Biol. 2010 Sep 20;190(6):1079-91
pubmed: 20837771
Br J Haematol. 1967 May;13(3):269-88
pubmed: 6025241
Biomed Mater. 2007 Sep;2(3):S121-5
pubmed: 18458455
Am J Physiol Cell Physiol. 2020 May 1;318(5):C848-C856
pubmed: 32159361
J Biol Chem. 1987 Jul 5;262(19):9412-20
pubmed: 3597417
Am J Respir Cell Mol Biol. 2021 Jan;66(1):86-95
pubmed: 34614384
Int J Mol Sci. 2020 Oct 14;21(20):
pubmed: 33066349
Physiol Rev. 2012 Jan;92(1):273-366
pubmed: 22298658
J Extracell Vesicles. 2019 Nov 25;9(1):1692417
pubmed: 31807237
Int J Mol Sci. 2021 Oct 29;22(21):
pubmed: 34769176
Invest Ophthalmol Vis Sci. 2015 Aug;56(9):5323-9
pubmed: 25015352
Transl Vis Sci Technol. 2020 Nov 02;9(12):1
pubmed: 33200043
Nat Cell Biol. 2018 Mar;20(3):332-343
pubmed: 29459780
Cells. 2020 Apr 26;9(5):
pubmed: 32357574
Blood. 2005 Sep 1;106(5):1604-11
pubmed: 15741221
Int J Biol Sci. 2021 Jan 1;17(1):163-177
pubmed: 33390841
J Extracell Vesicles. 2020 Jul 13;9(1):1790874
pubmed: 32939235
Eye (Lond). 2005 Oct;19(10):1106-14
pubmed: 16304591
PLoS Biol. 2012;10(12):e1001450
pubmed: 23271954
Br J Ophthalmol. 2011 May;95(5):604-12
pubmed: 20733027
Invest Ophthalmol Vis Sci. 1987 Oct;28(10):1668-77
pubmed: 3308758
Eye (Lond). 2003 Nov;17(8):949-56
pubmed: 14631402
Sci Rep. 2016 Mar 02;6:22519
pubmed: 26931825
Int J Mol Sci. 2017 Aug 23;18(9):
pubmed: 28832498
J Cell Biol. 2013 Feb 18;200(4):373-83
pubmed: 23420871
Anal Cell Pathol (Amst). 2021 Jul 22;2021:9983900
pubmed: 34336556
Invest Ophthalmol Vis Sci. 2019 May 1;60(6):2321-2329
pubmed: 31117124
J Immunol. 1994 Oct 1;153(7):3245-55
pubmed: 7522256
J Nanobiotechnology. 2020 Aug 14;18(1):113
pubmed: 32799868
Nanoscale. 2018 May 10;10(18):8547-8559
pubmed: 29693684
J Refract Surg. 2018 Jan 1;34(1):59-64
pubmed: 29315443
Invest Ophthalmol Vis Sci. 2018 Oct 1;59(12):5194-5200
pubmed: 30372747
Cancers (Basel). 2017 Jul 26;9(8):
pubmed: 28933725
Biol Reprod. 2021 Feb 11;104(2):457-467
pubmed: 33112369
Sci Rep. 2017 Feb 06;7:40548
pubmed: 28165027
Cornea. 2010 Apr;29(4):412-7
pubmed: 20164740
Int J Pharm. 2018 Dec 20;553(1-2):1-7
pubmed: 30316791
Prog Retin Eye Res. 2008 Mar;27(2):177-96
pubmed: 18243038
Stem Cell Reports. 2016 Oct 11;7(4):583-590
pubmed: 27693426
J Leukoc Biol. 2003 Aug;74(2):172-8
pubmed: 12885933
Am J Physiol Lung Cell Mol Physiol. 2013 Jun 1;304(11):L709-21
pubmed: 23564511
Cornea. 2009 Oct;28(9):989-96
pubmed: 19724214
Front Immunol. 2014 Sep 16;5:442
pubmed: 25278937
FEBS J. 2013 May;280(10):2120-37
pubmed: 23331954
Respir Res. 2019 Oct 30;20(1):240
pubmed: 31666080
Exp Mol Med. 2018 Apr 13;50(4):1-14
pubmed: 29651102
J Surg Res. 2007 Dec;143(2):281-5
pubmed: 17868699
Stem Cells. 2011 Oct;29(10):1572-9
pubmed: 21837654
Nat Rev Mol Cell Biol. 2022 May;23(5):369-382
pubmed: 35260831
Stem Cell Res Ther. 2019 Jan 31;10(1):47
pubmed: 30704535
Am J Respir Crit Care Med. 2021 Dec 15;204(12):1418-1432
pubmed: 34699335
Invest Ophthalmol Vis Sci. 1991 Dec;32(13):3221-37
pubmed: 1660857
Surv Ophthalmol. 2014 May-Jun;59(3):263-85
pubmed: 24461367
Cytotechnology. 2017 Dec;69(6):841-849
pubmed: 28497366
Invest Ophthalmol Vis Sci. 2013 Sep 27;54(9):6390-400
pubmed: 24078382
Br J Pharmacol. 2017 Dec;174(23):4205-4223
pubmed: 28865239
Annu Rev Cell Dev Biol. 2007;23:519-47
pubmed: 17506697
Clin Exp Ophthalmol. 2010 Mar;38(2):183-91
pubmed: 20398107
Cell Res. 2018 Jan;28(1):9-21
pubmed: 29076500
J Refract Surg. 2019 Aug 1;35(8):506-516
pubmed: 31393989
Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):12495-12500
pubmed: 29109268
Int J Mol Sci. 2022 Feb 02;23(3):
pubmed: 35163646
Small GTPases. 2017 Oct 2;8(4):220-232
pubmed: 27494381
Prog Retin Eye Res. 2015 Nov;49:1-16
pubmed: 26145225
Int J Mol Sci. 2022 Apr 14;23(8):
pubmed: 35457149
Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4689-92
pubmed: 14578387
Exp Eye Res. 2022 Mar;216:108940
pubmed: 35074340
J Ophthalmol. 2020 Nov 12;2020:5163484
pubmed: 33815833
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
J Refract Surg. 2018 Dec 1;34(12):790-798
pubmed: 30540361
Stem Cell Res. 2007 Nov;1(2):129-37
pubmed: 19383393
Wound Repair Regen. 2021 Nov;29(6):1062-1079
pubmed: 34655455
EMBO J. 2011 Aug 31;30(17):3481-500
pubmed: 21878991
J Biol Chem. 2013 Sep 6;288(36):26323-26334
pubmed: 23897813
iScience. 2019 Apr 26;14:199-209
pubmed: 30981115
Int J Ophthalmol. 2016 Mar 18;9(3):459-64
pubmed: 27158621
Lab Invest. 2006 Feb;86(2):106-15
pubmed: 16341020
Prog Retin Eye Res. 2015 Nov;49:17-45
pubmed: 26197361
Cell Commun Signal. 2019 Jul 10;17(1):73
pubmed: 31291956
Chem Rev. 2019 May 8;119(9):5607-5774
pubmed: 30859819
Front Bioeng Biotechnol. 2022 Apr 11;10:879192
pubmed: 35519619
Cell Stem Cell. 2018 Jun 01;22(6):834-849
pubmed: 29859174
Traffic. 2009 Oct;10(10):1528-42
pubmed: 19682328
Sci Rep. 2016 Nov 08;6:36162
pubmed: 27824088
J Exp Med. 1996 Mar 1;183(3):1161-72
pubmed: 8642258
Exp Eye Res. 2020 Dec;201:108272
pubmed: 33010289
Sci Rep. 2020 Sep 3;10(1):14521
pubmed: 32884023
Nat Cell Biol. 2021 Dec;23(12):1240-1254
pubmed: 34887515
J Cell Biochem. 2008 Dec 1;105(5):1211-8
pubmed: 18802920
Int J Mol Sci. 2022 Mar 15;23(6):
pubmed: 35328555
Stem Cell Res Ther. 2020 Nov 27;11(1):507
pubmed: 33246491
Biomolecules. 2021 Nov 12;11(11):
pubmed: 34827680
FASEB J. 2021 Jan;35(1):e21200
pubmed: 33341997
J Biol Chem. 2011 Dec 23;286(51):44162-44176
pubmed: 21865156
Invest Ophthalmol Vis Sci. 2012 Dec 19;53(13):8458-71
pubmed: 23150613
Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):1179-1186
pubmed: 28245298
Lancet Glob Health. 2017 Dec;5(12):e1221-e1234
pubmed: 29032195
Biochem J. 1991 Mar 1;274 ( Pt 2):381-6
pubmed: 1848755
Int J Mol Sci. 2021 Apr 08;22(8):
pubmed: 33917759
Clin Dermatol. 2007 Jan-Feb;25(1):9-18
pubmed: 17276196
Prog Retin Eye Res. 2013 Jan;32:102-80
pubmed: 22982179
J Extracell Vesicles. 2015 Nov 24;4:29159
pubmed: 26609807
J Extracell Vesicles. 2016 Jul 13;5:31295
pubmed: 27421995

Auteurs

Vincent Yeung (V)

Department of Ophthalmology, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, MA 02114, USA.

Nikolay Boychev (N)

Department of Ophthalmology, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, MA 02114, USA.

Wissam Farhat (W)

Department of Ophthalmology, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, MA 02114, USA.

Dimitrios P Ntentakis (DP)

Retina Service, Angiogenesis Laboratory, Department of Ophthalmology, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, MA 02114, USA.

Audrey E K Hutcheon (AEK)

Department of Ophthalmology, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, MA 02114, USA.

Amy E Ross (AE)

Department of Ophthalmology, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, MA 02114, USA.

Joseph B Ciolino (JB)

Department of Ophthalmology, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, MA 02114, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH